Related Experiment Video

Updated: Jun 22, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

New insights on pneumococcal disease: what we have learned over the past decade

Ron Dagan1

  • 1Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, P.O. Box 151, Beer-Sheva 84101, Israel. rdagan@bgu.ac.il

Vaccine
|June 26, 2009
PubMed

Insights

The seven-valent pneumococcal conjugate vaccine (PCV7) significantly reduced invasive pneumococcal diseases (IPDs) in children and provided indirect protection to older adults. PCV7 also lowered antibiotic-resistant Streptococcus pneumoniae infections.

Area of Science:

  • * Infectious Diseases
  • * Vaccinology
  • * Microbiology

Background:

  • * The introduction of the seven-valent pneumococcal conjugate vaccine (PCV7) in 2000 marked a significant advancement in preventing pneumococcal infections.
  • * Invasive pneumococcal diseases (IPDs) and mucosal infections caused by vaccine-specific serotypes were prevalent before PCV7 implementation.
  • * Concerns existed regarding the impact of pneumococcal conjugate vaccines on antibiotic resistance patterns.

Purpose of the Study:

  • * To evaluate the impact of PCV7 on the incidence of invasive pneumococcal diseases (IPDs) in vaccinated children and unvaccinated populations.
  • * To assess the effect of PCV7 on antibiotic-resistant Streptococcus pneumoniae isolates.
  • * To analyze the geographical variation in vaccine-serotype IPD incidence and its implications for future vaccine strategies.

Main Methods:

  • * Retrospective analysis of IPD incidence data before and after PCV7 introduction.
  • * Monitoring of antibiotic resistance trends in Streptococcus pneumoniae isolates.
  • * Geographical comparison of IPD rates across different regions.

Main Results:

  • * Significant reductions in IPD rates were observed in children under 5 years old, the primary target population for PCV7.
  • * A notable decrease in IPD rates was also observed in adults aged 65 years and older, indicating herd immunity.
  • * A concurrent decline in antibiotic-resistant Streptococcus pneumoniae isolates was documented following PCV7 widespread use.

Conclusions:

  • * PCV7 has been highly effective in reducing the burden of vaccine-type IPDs in young children and has conferred indirect protection to unvaccinated older adults.
  • * The widespread use of PCV7 has contributed to a reduction in antibiotic resistance among Streptococcus pneumoniae strains.
  • * Geographical variations in vaccine-serotype IPD incidence highlight the need for broader serotype coverage in future pneumococcal vaccines to maximize public health impact.

More Related Videos

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.